Navigating gene therapy QC: exploring the expanding AAV vector analytical toolkit

Cell & Gene Therapy Insights 2024; 10(6), 687–691

DOI: 10.18609/cgti.2024.082

Published: 12 June
Interview
Van Hoang



Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, speaks to Van Hoang, Head of Analytical and QC, Spark Therapeutics, exploring three key challenges in the field of AAV vector analytics and QC and how the expanding analytical toolkit can enable solutions to be found. They also discuss the development of novel technologies to gain a deeper understanding of the empty, full, and partially filled capsid analysis picture.